Iktos
Click to visit website
About
Iktos utilizes cutting-edge AI and robotics to revolutionize drug discovery. Through its platforms, including Makya for molecular design and Spaya for retrosynthesis, Iktos significantly accelerates the drug development process. By combining the creativity of generative AI with automated workflows, Iktos aims to reduce the drug discovery timeline to under two years, improving patient care through innovative treatments. Their autonomous lab automates the synthesis of compounds, ensuring high-throughput, while continuous data feeds allow for iterative optimization of drug candidates. Founded in 2016, Iktos has established collaborations with pharmaceutical and biotech firms to leverage its technology in drug development.
Platform
Task
Features
• high-throughput data generation
• generative ai technology for de novo drug design
• focus on synthetic accessibility
• real-time display of retrosynthetic routes
• customizable synthesis steps
• fully automated synthesis and analysis
• integration of purification and biological testing
Average Rating: 0.0
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
User Ratings
No ratings available.
Sign In to Rate this Tool
Alternatives
Denovo Sciences Platform
AI-powered platform for drug discovery using novel therapeutics and machine learning.
View Details
MindRank
AI-powered small molecule drug discovery platform accelerating drug development.
View Details
Featured Tools
Dezyn
Interactive architectural diagram tool with AI-powered features for flowcharts and cloud architectures.
View Details
Choice AI
Personalized OTT entertainment platform using AI for tailored viewing experiences.
View Details